EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Molecular and cellular mechanisms of pentadecanoic acid

Joseph Mercola

World Journal of Biological Chemistry · 05.12.2025 · 16 (4)

DOI: 10.4331/wjbc.v16.i4.111258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift World Journal of Biological Chemistry, online erschienen am 05.12.2025. Verfasst von Joseph Mercola. Beteiligte Einrichtung: Midwestern University, Downers Grove, IL 60515, United States. drm@mercola.com. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pentadecanoic acid (C15:0) is an odd-chain fatty acid, the β-oxidation of which yields propionyl-CoA that replenishes succinyl-CoA and tricarboxylic acid cycle flux; higher circulating levels are associated with reduced type 2 diabetes, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease, and mortality. Summarize the cellular and molecular mechanisms underlying these associations. A comprehensive literature search (2000-2025) identified studies of C15:0’s mechanistic actions in vitro and in vivo , and multi-omics studies focused on receptor binding, signaling cascades, gene expression, and comparative pharmacology. C15:0 is a dual partial peroxisome proliferator-activated receptor α/δ agonist. It activates AMP-activated protein kinase, suppresses mechanistic target of rapamycin, and selectively inhibits histone deacetylase 6. It augments succinate-driven complex II respiration, preserves mitochondrial membrane potential, limits reactive oxygen species, and attenuates interleukin-6 (IL-6) – triggered Janus kinase 2/signal transducer and activator of transcription 3 and nuclear factor kappa B p65 signaling, lowering monocyte chemoattractant protein-1, tumor necrosis factor-alpha, and IL-6. Across the BioMAP® human-primarycell platform – which tests 12 distinct primary human cell systems such as endothelial cells, fibroblasts, macrophages, and T-cells – C15:0 (17 µM) produced statistically significant changes in 36 mechanistically diverse biomarkers. This broad, multi-pathway modulation mirrors the phenotype produced by metformin and rapamycin, yet occurred with no detectable cytotoxicity, paralleling metformin and rapamycin with negligible cytotoxicity. C15:0 engages receptor targets that converge on enhanced lipid oxidation, cellular energetics, and inflammation resolution. Although prospective clinical outcomes are still lacking, the pleiotropic mechanism profile positions C15:0 as a potentially unique nutraceutical or adjunct therapeutic candidate. Further research is warranted to confirm its clinical impacts, optimize dosing, and clarify long-term safety as an essential fatty acid supporting metabolic and immune homeostasis.

Schlagwörter

Stichwörter der Autor:innen

Adenosine monophosphate activated protein kinaseAnti-inflammatory signalingHistone deacetylase six inhibitionMetabolic healthMitochondrial bioenergeticsNutraceutical potentialOdd chain saturated fatty acidsPentadecanoic acidPeroxisome proliferator activated receptors

Autor:innen und Institutionen

  • Midwestern University, Downers Grove, IL 60515, United States. drm@mercola.com.

Zitieren

APA

Mercola, J. (2025). Molecular and cellular mechanisms of pentadecanoic acid. World Journal of Biological Chemistry, 16(4). https://doi.org/10.4331/wjbc.v16.i4.111258

Vancouver

Mercola J. Molecular and cellular mechanisms of pentadecanoic acid. World Journal of Biological Chemistry. 2025;16(4). doi:10.4331/wjbc.v16.i4.111258

BibTeX
@article{Mercola2025,
  author = {Mercola, Joseph},
  title = {Molecular and cellular mechanisms of pentadecanoic acid},
  journal = {World Journal of Biological Chemistry},
  year = {2025},
  volume = {16},
  number = {4},
  doi = {10.4331/wjbc.v16.i4.111258}
}
Kostenlos starten →